Oireachtas Joint and Select Committees
Wednesday, 21 November 2018
Joint Oireachtas Committee on Health
Evaluating Orphan Drugs: Discussion (Resumed)
9:00 am
Rose Conway Walsh (Sinn Fein) | Oireachtas source
It is obscure. Is Dr. Mitchell clear on the cost-benefit analysis that is used in the context of how many negative or positive externalities are taken into account or how the decision is arrived at? Is it long, short or medium term?
No comments